GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Talkspace Inc (NAS:TALK) » Definitions » Risk Assessment

TALK (Talkspace) Risk Assessment


View and export this data going back to 2021. Start your Free Trial

What is Talkspace Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Talkspace is: No Data: Cannot be evaluated.


Competitive Comparison of Talkspace's Risk Assessment

For the Health Information Services subindustry, Talkspace's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Talkspace's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Talkspace's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Talkspace's Risk Assessment falls into.



Talkspace  (NAS:TALK) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


Talkspace Risk Assessment Related Terms

Thank you for viewing the detailed overview of Talkspace's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.


Talkspace Business Description

Traded in Other Exchanges
N/A
Address
622 Third Avenue, New York, NY, USA, 10017
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue primarily stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
Executives
Gil Margolin officer: Chief Technology Officer C/O TALKSPACE NETWORK LLC, 2578 BROADWAY #607, NEW YORK NY 10025
Steven Dziedzic officer: Chief Product Officer C/O TALKSPACE, INC., 2578 BROADWAY #607, NEW YORK NY 10025
John Charles Reilly officer: General Counsel and Secretary C/O TALKSPACE NETWORK LLC, 2578 BROADWAY #607, NEW YORK NY 10025
Jon R Cohen director C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Michael E Hansen director C/O TALKSPACE, INC., 2578 BROADWAY #607, NEW YORK NY 10025
Douglas L Braunstein director, officer: President, Chairman HUDSON EXECUTIVE CAPITAL LP, 570 LEXINGTON AVENUE, 35TH FLOOR, NEW YORK NY 10022
Jeffrey Crowe director 525 UNIVERSITY AVENUE, SUITE 800, PALO ALTO CA 94301
Hudson Executive Capital Lp 10 percent owner C/O CADWALADER, WICKERSHAM & TAFT, LLP, 200 LIBERTY STREET, NEW YORK NY 10281
Erin Boyd officer: Chief Growth Officer C/O TALKSPACE, INC., 2578 BROADWAY #607, NEW YORK NY 10025
Jennifer Fulk officer: Chief Financial Officer C/O TALKSPACE NETWORK LLC, 2578 BROADWAY #607, NEW YORK NY 10025
Hec Management Gp Llc 10 percent owner 1185 AVENUE OF THE AMERICAS, 32ND FLOOR, NEW YORK NY 10036
Curtis Warfield director 6040 DUTCHMANS LANE, LOUISVILLE KY 40205
Erez Shachar director C/O EVERGREEN VENTURE PARTNERS, 25 HABARZEL ST., TEL-AVIV L3 69710
Mark Hirschhorn officer: President, COO and CFO
Jacqueline E Yeaney director 2002 SUMMIT BOULEVARD, SUITE 100, ATLANTA GA 30319